Search research articles
Contact Us
Filters
Showing results (51-60 of 190) with videos related to
Page
of 19
Sort By:
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
January 8, 2024
Evaluating Policies of Expanding Versus Restricting First-Line Treatment Choices: A Cost-Effectiveness Analysis Framework
Boshen Jiao, Josh J Carlson, Louis P Garrison, et al.
Pharmacoeconomics
|
April 12, 2006
Post-exposure influenza prophylaxis with oseltamivir: cost effectiveness and cost utility in families in the UK
Beate Sander, Frederick G Hayden, Marlene Gyldmark, et al.
Journal of Medical Economics
|
April 28, 2018
Heart rate variability testing: could it change spending for rheumatoid arthritis patients in the United States? An exploratory economic analysis
Marita Zimmermann, Elisabeth Vodicka, Andrew J Holman, et al.
Obesity (Silver Spring, Md.)
|
July 20, 2017
Cost and Health Care Utilization Implications of Bariatric Surgery Versus Intensive Lifestyle and Medical Intervention for Type 2 Diabetes
Souvik Banerjee, Louis P Garrison, David R Flum, et al.
Journal of Managed Care & Specialty Pharmacy
|
April 26, 2022
International reference pricing of pharmaceuticals in the United States: Implications for potentially curative treatments
Sean D Sullivan, Kiera D Sullivan, Omar Dabbous, et al.
Clinical Therapeutics
|
March 13, 2013
Comparative-effectiveness research to aid population decision making by relating clinical outcomes and quality-adjusted life years
Jonathan D Campbell, Judy Zerzan, Louis P Garrison, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
June 16, 2019
Novel Approaches to Value Assessment Within the Cost-Effectiveness Framework
Louis P Garrison, Jeroen P Jansen, Nancy J Devlin, et al.
Health Affairs (Project Hope)
|
October 6, 2010
A flexible approach to evidentiary standards for comparative effectiveness research
Louis P Garrison, Peter J Neumann, Paul Radensky, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
July 7, 2019
How Does Option Value Affect the Potential Cost-Effectiveness of a Treatment? The Case of Ipilimumab for Metastatic Melanoma
Meng Li, Anirban Basu, Caroline Bennette, et al.
Journal of Medical Economics
|
May 14, 2019
Determinants of specialist physician ambulatory visits: a neurology example
David N van der Goes, John P Ney, Louis P Garrison
Page
of 19
Search research articles
Search
Showing results (51-60 of 190) with videos related to
Sort By:
Page
of 19
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
January 8, 2024
Evaluating Policies of Expanding Versus Restricting First-Line Treatment Choices: A Cost-Effectiveness Analysis Framework
Boshen Jiao, Josh J Carlson, Louis P Garrison, et al.
Pharmacoeconomics
|
April 12, 2006
Post-exposure influenza prophylaxis with oseltamivir: cost effectiveness and cost utility in families in the UK
Beate Sander, Frederick G Hayden, Marlene Gyldmark, et al.
Journal of Medical Economics
|
April 28, 2018
Heart rate variability testing: could it change spending for rheumatoid arthritis patients in the United States? An exploratory economic analysis
Marita Zimmermann, Elisabeth Vodicka, Andrew J Holman, et al.
Obesity (Silver Spring, Md.)
|
July 20, 2017
Cost and Health Care Utilization Implications of Bariatric Surgery Versus Intensive Lifestyle and Medical Intervention for Type 2 Diabetes
Souvik Banerjee, Louis P Garrison, David R Flum, et al.
Journal of Managed Care & Specialty Pharmacy
|
April 26, 2022
International reference pricing of pharmaceuticals in the United States: Implications for potentially curative treatments
Sean D Sullivan, Kiera D Sullivan, Omar Dabbous, et al.
Clinical Therapeutics
|
March 13, 2013
Comparative-effectiveness research to aid population decision making by relating clinical outcomes and quality-adjusted life years
Jonathan D Campbell, Judy Zerzan, Louis P Garrison, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
June 16, 2019
Novel Approaches to Value Assessment Within the Cost-Effectiveness Framework
Louis P Garrison, Jeroen P Jansen, Nancy J Devlin, et al.
Health Affairs (Project Hope)
|
October 6, 2010
A flexible approach to evidentiary standards for comparative effectiveness research
Louis P Garrison, Peter J Neumann, Paul Radensky, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
July 7, 2019
How Does Option Value Affect the Potential Cost-Effectiveness of a Treatment? The Case of Ipilimumab for Metastatic Melanoma
Meng Li, Anirban Basu, Caroline Bennette, et al.
Journal of Medical Economics
|
May 14, 2019
Determinants of specialist physician ambulatory visits: a neurology example
David N van der Goes, John P Ney, Louis P Garrison
Page
of 19